Mediheal Turns Domestic Records into American Growth

U.S. consumers increasingly turn to K-beauty for science-backed, results-driven skincare, global derma-cosmetic brand Mediheal continues to distinguish itself as a category leader, backed by record-setting sales performance at South Korea’s most influential beauty retailer, Olive Young.

It was recently announced that Mediheal was named the No. 1 brand in total sales at Olive Young for a second straight year (2024-2025), topping more than 3,000 brands and becoming the first to achieve this distinction twice since the retailer’s founding in 1999. Widely considered the Korean equivalent of Ulta or Sephora, Olive Young’s success is a strong indicator of global relevance and long-term consumer trust.

Mediheal earned four major honours at the Olive Young Awards:

1 in the Toner Pad category
Global Trend Best Performer with the Madecassoside Blemish Pad
Global Trend Rising with the Madecassoside Blemish serum
Winner in the Mask category with Madecassoside Essential Sheet Mask

Among the award-winning Olive Young products, Mediheal’s Madecassoside Blemish Pad ranked No. 1 in its category for the second consecutive year, and the Madecassoside Blemish Repair serum recorded an 820 percent increase in sales within one year of launch, solidifying madecassoside as a hero ingredient driving global demand.

The brand’s momentum also took hold in the U.S. During the Black Friday and Cyber Monday period, Mediheal’s Retinol Collagen Eye Patch ranked No. 1 in Amazon’s “Movers & Shakers in Beauty & Personal Care” category, a designation that highlights the fastest-rising products based on sharp gains within a 24-hour period.

Since 2009, Mediheal’s core product lines, including toner pads, serums, and sheet masks, have driven the brand’s growth in the U.S. and around the world. To date, Mediheal has sold more than 3.3 billion sheet masks globally, earning the No. 1 mask ranking for 15 consecutive years at Olive Young, and has sold more than 32 million toner pads worldwide. Now available in 36 countries, the brand continues to expand its international footprint, including in the U.S., where it is sold through major retail partners such as Ulta Beauty, Target, and Costco, as well as select specialty beauty channels, with additional global retail partnerships currently in the pipeline.

Building A Bridge from Seoul’s Trend Centers to American Vanity Shelves

According to Johanna Kim, CEO and Creative Director of Mediheal, the brand’s success at Olive Young serves as a critical barometer for future international growth. Kim noted that because Olive Young is the primary discovery point for K-beauty trends, the high performance of their Madecassoside line provides the necessary validation for their 2026 roadmap. This domestic momentum is now being used as a springboard to scale proven Korean innovations across the U.S. and other global markets.

In addition, Mediheal’s recent achievements are the result of a company-wide brand transformation and organisational restructuring over the past three years, driven by new leadership and a renewed focus on agility. Through this evolution, the brand has strengthened its ability to respond to rapid market changes through innovative product development, data-driven, agile marketing strategies, and a disciplined, strategic approach to distribution. The brand remains deeply committed to integrating diverse consumer insights, needs, and real-time feedback into every aspect of its product and brand strategy.

As American retailers and consumers continue to embrace K-Beauty and the category evolves from trend to trusted standard in the U.S., Mediheal’s dominance in Korea offers a clear preview of the derma-cosmetic brand’s continued expansion and influence with American consumers.